Analyst Rating Changes — Upgrades, Downgrades & Price Targets

658 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Analyst Downgrades

WhenStockChange FirmAnalyst RatingPrice Target
Jul 09
13:57 UTC
SPG
Simon Property Group
↓ Downgrade Deutsche Bank Aktiengesellschaft firm only Buy Hold $220.00
Jul 09
13:57 UTC
RYAN
Ryan Specialty
↓ Downgrade Wolfe Research firm only Outperform Peer Perform
Jul 09
13:57 UTC
MAT
Mattel
↓ Downgrade The Goldman Sachs Group Stephen Laszczyk ★★★☆☆ #1710 Neutral Sell $12.00
Jul 09
13:57 UTC
GSBD
Goldman Sachs BDC
↓ Downgrade The Goldman Sachs Group firm only Neutral Reduce $8.50
Jul 09
13:57 UTC
EQH
Equitable
↓ Downgrade Wolfe Research firm only Outperform Peer Perform
Jul 09
13:57 UTC
DCO
Ducommun
↓ Downgrade Royal Bank Of Canada Ken Herbert not yet tracked Outperform Sector Perform
Jul 09
13:57 UTC
AJG
Arthur J. Gallagher & Co.
↓ Downgrade Wolfe Research firm only Outperform Peer Perform
Jul 09
12:57 UTC
PNR
Pentair
↓ Downgrade Wolfe Research Nigel Coe ★★★☆☆ #1644 Outperform Peer Perform
Jul 09
12:57 UTC
MAT
Mattel
↓ Downgrade The Goldman Sachs Group Stephen Laszczyk ★★★☆☆ #1710 Neutral Sell
Jul 09
12:57 UTC
GSBD
Goldman Sachs BDC
↓ Downgrade The Goldman Sachs Group firm only Neutral Reduce
Jul 09
12:57 UTC
GGG
Graco
↓ Downgrade Wolfe Research Brad Hewitt ★★★☆☆ #1632 Outperform Peer Perform
Jul 09
12:57 UTC
AVAV
AeroVironment
↓ Downgrade Royal Bank Of Canada Ken Herbert not yet tracked Outperform Sector Perform $180.00
Jul 09
11:57 UTC
TECH
Bio-Techne
↓ Downgrade Royal Bank Of Canada Dan Leonard ★★★☆☆ #1400 Outperform Sector Perform
Jul 09
11:57 UTC
SEGXF
SEGRO
↓ Downgrade Jefferies Financial Group firm only Buy Hold
Jul 09
11:57 UTC
PNR
Pentair
↓ Downgrade Wolfe Research firm only Outperform Peer Perform
Jul 09
11:57 UTC
GGG
Graco
↓ Downgrade Wolfe Research firm only Outperform Peer Perform
Jul 09
11:57 UTC
FCNCA
First Citizens BancShares
↓ Downgrade Citigroup firm only Neutral Market Perform
Jul 09
11:57 UTC
AVAV
AeroVironment
↓ Downgrade Royal Bank Of Canada Ken Herbert not yet tracked Outperform Sector Perform
Jul 09
10:57 UTC
CVSG
CVS Group
↓ Downgrade Jefferies Financial Group firm only Hold GBX 1,420 GBX 1,350-4.9%
Jul 09
05:56 UTC
UHS
Universal Health Services
↓ Downgrade Barclays Andrew Mok not yet tracked Overweight Negative $179.00
Jul 09
05:56 UTC
HCA
HCA Healthcare
↓ Downgrade Barclays Andrew Mok not yet tracked Overweight Negative $427.00
Jul 09
00:55 UTC
UHS
Universal Health Services
↓ Downgrade Barclays Andrew Mok not yet tracked Overweight Negative
Jul 09
00:55 UTC
SBRA
Sabra Healthcare REIT
↓ Downgrade Truist Financial Michael Lewis ★★★★★ #215 Buy Hold
Jul 09
00:55 UTC
RIO
Rio Tinto
↓ Downgrade Morgan Stanley firm only Equal Weight Underweight
Jul 09
00:55 UTC
PGPHF
Partners Group
↓ Downgrade UBS Group firm only Buy Neutral
Jul 09
00:55 UTC
HCA
HCA Healthcare
↓ Downgrade Barclays Andrew Mok not yet tracked Overweight Negative
Jul 09
00:55 UTC
GLOB
Globant
↓ Downgrade Itau BBA Securities Maria Clara Infantozzi not yet tracked Outperform Market Perform $39.00
Jul 09
00:55 UTC
DLTR
Dollar Tree
↓ Downgrade The Goldman Sachs Group Kate McShane ★☆☆☆☆ #2454 Neutral Sell
Jul 09
00:55 UTC
CYH
Community Health Systems
↓ Downgrade Barclays Andrew Mok not yet tracked Equal Weight Underweight $3.00
Jul 09
00:55 UTC
CRM
Salesforce
↓ Downgrade KeyCorp Jackson Ader ★★★★☆ #464 Overweight Sector Weight
Jul 09
00:55 UTC
BBWI
Bath & Body Works
↓ Downgrade The Goldman Sachs Group Kate McShane ★☆☆☆☆ #2454 Neutral Sell $23.00 $19.00-17.4%
Jul 09
00:55 UTC
BBOT
BridgeBio Oncology Therapeutics
↓ Downgrade UBS Group firm only Overweight
Jul 09
00:55 UTC
APEMY
Aperam
↓ Downgrade BNP Paribas Exane firm only Neutral Underperform
Jul 09
00:55 UTC
ANIOY
Acerinox
↓ Downgrade BNP Paribas Exane firm only Neutral Underperform
Jul 08
20:55 UTC
PGPHF
Partners Group
↓ Downgrade UBS Group firm only Buy Neutral
Jul 08
15:54 UTC
DLTR
Dollar Tree
↓ Downgrade The Goldman Sachs Group Kate McShane ★☆☆☆☆ #2454 Neutral Sell
Jul 08
14:54 UTC
RIO
Rio Tinto
↓ Downgrade Morgan Stanley firm only Equal Weight Underweight
Jul 08
14:54 UTC
APEMY
Aperam
↓ Downgrade BNP Paribas Exane firm only Neutral Underperform
Jul 08
14:54 UTC
ANIOY
Acerinox
↓ Downgrade BNP Paribas Exane firm only Neutral Underperform
Jul 08
13:54 UTC
SBRA
Sabra Healthcare REIT
↓ Downgrade Truist Financial Michael Lewis ★★★★★ #215 Buy Hold
Jul 08
13:54 UTC
RIO
Rio Tinto
↓ Downgrade Morgan Stanley firm only Overweight Underweight
Jul 08
12:54 UTC
UHS
Universal Health Services
↓ Downgrade Barclays Andrew Mok not yet tracked Overweight Negative
Jul 08
12:54 UTC
HCA
HCA Healthcare
↓ Downgrade Barclays Andrew Mok not yet tracked Overweight Negative
Jul 08
12:54 UTC
GLOB
Globant
↓ Downgrade Itau BBA Securities Maria Clara Infantozzi not yet tracked Outperform Market Perform $39.00
Jul 08
12:54 UTC
CYH
Community Health Systems
↓ Downgrade Barclays Andrew Mok not yet tracked Equal Weight Underweight $3.00
Jul 08
12:54 UTC
BBWI
Bath & Body Works
↓ Downgrade The Goldman Sachs Group Kate McShane ★☆☆☆☆ #2454 Neutral Sell $23.00 $19.00-17.4%
Jul 08
11:21 UTC
BBWI
Bath & Body Works
↓ Downgrade The Goldman Sachs Group Kate McShane ★☆☆☆☆ #2454 Neutral Sell
Jul 08
09:21 UTC
BBOT
BridgeBio Oncology Therapeutics
↓ Downgrade UBS Group firm only Overweight
Jul 08
05:20 UTC
GLOB
Globant
↓ Downgrade Itau BBA Securities firm only Market Perform
Jul 08
00:20 UTC
TBPH
Theravance Biopharma
↓ Downgrade HC Wainwright Douglas Tsao ★★★☆☆ #1034 Buy Neutral $15.00 $17.00+13.3%
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 2 / 14 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.